Company DURECT Corporation Deutsche Boerse AG
Equities
DC8A
US2666055007
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.33 EUR | -2.92% | +9.92% | +153.33% |
05-21 | DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis | CI |
05-21 | Sector Update: Health Care Stocks Edge Higher Tuesday Afternoon | MT |
Business Summary
Number of employees: 48
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Products
100.0
%
| 19 | 100.0 % | 9 | 100.0 % | -55.67% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
54.0
%
| 5 | 28.2 % | 5 | 54.0 % | -15.24% |
Europe
26.9
%
| 12 | 61.1 % | 2 | 26.9 % | -80.49% |
Others
12.5
%
| 1 | 2.9 % | 1 | 12.5 % | +92.46% |
Japan
6.5
%
| 1 | 7.7 % | 1 | 6.5 % | -62.43% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
James Brown
FOU | Founder | 67 | 05/02/98 |
Timothy Papp
DFI | Director of Finance/CFO | 48 | 30/06/22 |
Wei Qi Lin
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/07 |
Judy Joice
COO | Chief Operating Officer | 67 | 30/06/07 |
David J. Ellis
CTO | Chief Tech/Sci/R&D Officer | - | 31/10/11 |
Norman Sussman
CTO | Chief Tech/Sci/R&D Officer | 71 | 01/11/20 |
Keith L. Lui
PRN | Corporate Officer/Principal | - | 30/04/20 |
General Counsel | 63 | 28/02/22 | |
Steve Helmer
PRN | Corporate Officer/Principal | - | - |
Jian Li
AUD | Comptroller/Controller/Auditor | 53 | 29/02/00 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
James Brown
FOU | Founder | 67 | 05/02/98 |
Peter García
BRD | Director/Board Member | 62 | 12/12/21 |
Mohammad Azab
BRD | Director/Board Member | 68 | 03/01/21 |
Gail Maderis
CHM | Chairman | 66 | 03/01/21 |
Director/Board Member | 81 | 30/11/06 | |
Gail Farfel
BRD | Director/Board Member | 60 | 24/04/19 |
Judith Robertson
BRD | Director/Board Member | 64 | 22/04/19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 31,039,381 | 29,186,315 ( 94.03 %) | 0 | 94.03 % |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.57B | |
+3.23% | 22.82B | |
-10.44% | 18.19B | |
-41.74% | 16.54B | |
-13.31% | 16.5B | |
+2.44% | 13.39B | |
+27.89% | 11.1B |
- Stock Market
- Equities
- DRRX Stock
- DC8A Stock
- Company DURECT Corporation